Hasil Pencarian (1)
small molecule | CAS: 1018899-04-1
Sotagliflozin is a dual inhibitor of SGLT1 and SGLT2, the first of its kind,[A244499] which is approved for use in the EU, in combination with insulin, to improve glycemic control in patients with type 1 diabetes mellitus (T1DM) and a BMI ?27 kg/m<sup>2</sup>…
Kategori:
Alimentary Tract and MetabolismBCRP/ABCG2 InhibitorsBlood Glucose Lowering Agents
+24
Target Protein:
Sodium/glucose cotransporter 2Sodium/glucose cotransporter 1
Waktu ParuhThe mean terminal h…
Vol. DistribusiSotagliflozin has a…
KlirensIn healthy voluntee…
Genetik
-